课题基金 / 基金详情

Role of Monocytes in AIDS and as Targets for Antiviral Therapy

Role of Monocytes in AIDS and as Targets for Antiviral Therapy
单核细胞在艾滋病中的作用及其作为抗病毒治疗的靶标
批准号:
6104610
负责人:
Sharon M Wahl
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Sharon M Wahl的其他基金

相似基金

相关文献

中文摘要
翻译
尽管HIV-1在口腔中存在,
英文摘要
Despite the presence of HIV-1 in the oral cavity, transmission of the virus through saliva is rare which implicates innate/natural antiviral mechanisms for suppressing transmission. One such endogenous antiviral molecule, secretory leukocyte protease inhibitor (SLPI), inhibits HIV-1 infection of mononuclear cells during or soon after internalization. To further clarify the function of SLPI in innate/host defense, efforts are underway to generate mice homozygous for a null mutation of SLPI. In additional studies focusing on the regulation of HIV production after infection, opportunistic pathogens were shown to influence viral replication. By in situ hybridization, unprecedented levels of HIV were detected in co-infected tissues. Mycobacterium avium promotes HIV infection by activating the transcription factor NF-kappaB, stimulating cytokine and chemokine production and HIV co-receptor (CCR5) expression. The dynamic relationship between opportunistic pathogens, macrophages and high levels of viral replication emphasize that treatment of co-infections is important for controlling HIV production and plasma viremia, particularly in late-stage HIV-disease. In addition to opportunistic pathogens, mucosal inflammation also exacerbates HIV production and therapeutic intervention dramatically reduces viral burden, emphasizing the negative contribution of immune activation to the clinical course of AIDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Normal And Pathologic Mechanisms Of Inflammation, Innate And Acquired Immunity
Normal And Pathologic Mechanisms Of Inflammation, Innate And Acquired Immunity
Normal and Pathologic Mechanisms of Inflammation, Innate and Acquired Immunity
Clinical Investigations in Infectious and Autoimmune Diseases
海外基金